Posted on 1/26/21
Nirogy Therapeutics Closes $16.5 Million Series A Financing
Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules to target cellular transporters, today announced the closing of a $16.5 million Series A financing.
Posted on 1/26/21
Pacira BioSciences Equity Invest in GeneQuine Biotherapeutics
PARSIPPANY, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today announced that the . . .
Posted on 1/26/21
Grant Avenue Capital Acquires Valeo Home Health and Hospice
Grant Avenue Capital, LLC, a healthcare-focused private equity firm, announced today that it acquired a majority interest in Valeo Home Health and Hospice, based in Salt . . .
Posted on 1/26/21
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
With the U.S. starting to open up more but a full reopening only possible once we achieve widespread vaccination, the personal-finance website WalletHub today released updated . . .
Posted on 1/26/21
Why Pfizer's Future Looks Better in 2021
Despite the success of its COVID-19 vaccine program, Pfizer(NYSE:PFE) didn't impress investors with its stock performance last year. That could change going forward, though. In this . . .
Posted on 1/26/21
Merck Gives Up on Coronavirus Vaccines
Pharmaceutical giant Merck (NYSE:MRK) officially threw in the towel on its efforts to develop a COVID-19 vaccine. The company said it's discontinuing the development of two . . .
Posted on 1/26/21
Is Moderna a Smart Pick for Long-Term Investors?
There's no question that Moderna (NASDAQ:MRNA) has been a big winner for investors. The biotech stock skyrocketed 434% in 2020. But can the company keep the . . .
Posted on 1/26/21
Moderna Says Vaccine Protects Against All Known Variants
Moderna (NASDAQ:MRNA) announced evidence that its COVID-19 vaccine is protective against all variants of the SARS-CoV-2 virus detected to date, including two strains first detected in . . .
Posted on 1/26/21
Ferguson Blasts Pace Of Maryland’s COVID-19 Vaccine Rollout Plan
Senate President Bill Ferguson Monday reiterated his criticism at the pace of the Hogan administration’s coronavirus vaccine rollout plan.“We are 40 out of 50 states in . . .
Posted on 1/26/21
Chimerix Closes Public Offering of Common Stock
DURHAM, N.C., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and . . .
Posted on 1/26/21
Caladrius Biosciences Closes $25.0 Million Private Placement
BASKING RIDGE, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed . . .
Posted on 1/26/21
Phio Pharmaceuticals Closes $14M Private Placement
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 1/26/21
Seelos Therapeutics Proposes Public Offering of Common Stock
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, announced today that . . .
Posted on 1/26/21
OncoSec Medical Closes $42.0 Million Public Offering of Common Stock
OncoSec Medical Incorporated (NASDAQ:ONCS), a late-stage biotechnology company focused on designing, developing and commercializing innovative therapies and proprietary medical approaches to stimulate and guide an anti-tumor . . .
Posted on 1/26/21
INOVIO Closes Public Offering of Common Stock
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, including . . .
Posted on 1/26/21
Maryland’s Average COVID-19 Positive Test Rate Declines for a Week
The percentage of Maryland’s coronavirus tests that have come back positive over the last seven days continues to decrease, with the average reaching 6.84% on Monday.The . . .
Posted on 1/26/21
Method Health Presents Free Webinar Series “Method Health Live”
The free series kicks off with “Female Hormones: Balance and Restoration”Method Health, a premier health optimization medical facility in South Florida, presents Method Health Live, a . . .
Posted on 1/25/21
East Boston Neighborhood Health Center Expands Pediatric Practice at South End Community Health Center
Caroline Castleforte, M.D. brings more than 14 years of experience to new roleAs part of its recent expansion into the South End, East Boston Neighborhood Health . . .
Posted on 1/25/21
Ciena Corporation Is Sending Mixed Signals
SummaryCiena recorded its first quarterly contraction in years and guidance calls for another one in Q1.Ciena managed to score gains elsewhere despite encountering challenges, including higher . . .
Posted on 1/25/21
Citius Pharmaceuticals Announces $20.0 Million Private Placement
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into securities purchase . . .
Posted on 1/25/21
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine . . .
Posted on 1/25/21
TScan Therapeutics Closes $100 Million Series C Financing
TScan Therapeutics, a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies in oncology, today announced the closing of an oversubscribed . . .
Posted on 1/25/21
Advaxis Reports Fiscal Year 2020 Financial Results and Provides a Business Update
PRINCETON, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today . . .
Posted on 1/25/21
What Kind of Deals Is Pfizer Planning for the Next Few Years?
Pfizer(NYSE:PFE) has a long and storied history of deal-making. And the big drugmaker's business development activities aren't likely to fall by the wayside in 2021. In . . .
Posted on 1/25/21
Why Pfizer's Future Looks Better in 2021
Despite the success of its COVID-19 vaccine program, Pfizer(NYSE:PFE) didn't impress investors with its stock performance last year. That could change going forward, though. In this . . .
